Although T-VEC treatment led only to minor levels of cell death and low exposure of PS, we found substantial CRT translocation and ATP release that was comparable to or even exceeded levels obtained when treating melanoma cell lines with chemical CDI agents. Here, CALR is linked to melanoma.